Home/Pipeline/BL-001

BL-001

Obesity

Phase 1bActive

Key Facts

Indication
Obesity
Phase
Phase 1b
Status
Active
Company

About Bloom Science

Bloom Science is developing a new class of gut-brain axis therapeutics, with a lead candidate designed to mimic the ketogenic diet's effects without its restrictive regimen. The company has reported positive Phase 1 data for BL-001 in obesity and is planning Phase 2 trials in both obesity and Dravet syndrome, a severe form of epilepsy. Its proprietary IrisRx™ platform integrates synthetic biology and a microbial knowledgebase to engineer commensal bacteria for broad therapeutic potential. As a private, pre-revenue company, Bloom is positioning itself in the competitive but high-growth microbiome and metabolic health spaces.

View full company profile

About Bloom Science

Bloom Science is developing a new class of gut-brain axis therapeutics, with a lead candidate designed to mimic the ketogenic diet's effects without its restrictive regimen. The company has reported positive Phase 1 data for BL-001 in obesity and is planning Phase 2 trials in both obesity and Dravet syndrome, a severe form of epilepsy. Its proprietary IrisRx™ platform integrates synthetic biology and a microbial knowledgebase to engineer commensal bacteria for broad therapeutic potential. As a private, pre-revenue company, Bloom is positioning itself in the competitive but high-growth microbiome and metabolic health spaces.

View full company profile

Other Obesity Drugs

DrugCompanyPhase
LET003Harbour BioMedDiscovery
LET001Harbour BioMedDiscovery
RGT-075Regor TherapeuticsPhase 2b
Anti‑Obesity Oral DrugPremas BiotechPhase 1
Obesity Target Discovery CollaborationFauna BioTarget Discovery/Preclinical
GLP-1 variantsHeligenicsDiscovery
MYO Platform (Metabolic Disease)RenbioPre-clinical
Obesity Clinical TrialsIMA Clinical ResearchNot Applicable (Service)
KAYO-2000KayoTheraPreclinical
MVD-1 (SANA)Eolo PharmaPhase 1
GIP-neutralizing antibodyHelicore BiopharmaPre-clinical
Antral Gastroplasty / Endoscopic SleeveEndo-TAGSSPre-clinical